Analysis | Samples | Factors | Units |
---|---|---|---|
Reversed phase POSITIVE ION MODE | Celecoxib_HFD_1 | Treatment:Celecoxib_HFD | height |
Reversed phase POSITIVE ION MODE | Celecoxib_HFD_2 | Treatment:Celecoxib_HFD | height |
Reversed phase POSITIVE ION MODE | Celecoxib_HFD_3 | Treatment:Celecoxib_HFD | height |
Reversed phase POSITIVE ION MODE | Celecoxib_HFD_4 | Treatment:Celecoxib_HFD | height |
Reversed phase POSITIVE ION MODE | Celecoxib_HFD_5 | Treatment:Celecoxib_HFD | height |
Reversed phase POSITIVE ION MODE | Celecoxib_HFD_6 | Treatment:Celecoxib_HFD | height |
Reversed phase POSITIVE ION MODE | Celecoxib_HFD_7 | Treatment:Celecoxib_HFD | height |
Reversed phase POSITIVE ION MODE | Celecoxib_HFD_8 | Treatment:Celecoxib_HFD | height |
Reversed phase POSITIVE ION MODE | Celecoxib_HFD_9 | Treatment:Celecoxib_HFD | height |
Reversed phase POSITIVE ION MODE | CFD_1 | Treatment:CFD | height |
Reversed phase POSITIVE ION MODE | CFD_2 | Treatment:CFD | height |
Reversed phase POSITIVE ION MODE | CFD_3 | Treatment:CFD | height |
Reversed phase POSITIVE ION MODE | CFD_4 | Treatment:CFD | height |
Reversed phase POSITIVE ION MODE | CFD_5 | Treatment:CFD | height |
Reversed phase POSITIVE ION MODE | CFD_6 | Treatment:CFD | height |
Reversed phase POSITIVE ION MODE | CFD_7 | Treatment:CFD | height |
Reversed phase POSITIVE ION MODE | CFD_8 | Treatment:CFD | height |
Reversed phase POSITIVE ION MODE | HFD_1 | Treatment:HFD | height |
Reversed phase POSITIVE ION MODE | HFD_2 | Treatment:HFD | height |
Reversed phase POSITIVE ION MODE | HFD_3 | Treatment:HFD | height |
Reversed phase POSITIVE ION MODE | HFD_4 | Treatment:HFD | height |
Reversed phase POSITIVE ION MODE | HFD_5 | Treatment:HFD | height |
Reversed phase POSITIVE ION MODE | HFD_6 | Treatment:HFD | height |
Reversed phase POSITIVE ION MODE | HFD_7 | Treatment:HFD | height |
Reversed phase POSITIVE ION MODE | HFD_8 | Treatment:HFD | height |
Reversed phase POSITIVE ION MODE | HFD_9 | Treatment:HFD | height |
Reversed phase NEGATIVE ION MODE | Celecoxib_HFD_1 | Treatment:Celecoxib_HFD | height |
Reversed phase NEGATIVE ION MODE | Celecoxib_HFD_2 | Treatment:Celecoxib_HFD | height |
Reversed phase NEGATIVE ION MODE | Celecoxib_HFD_3 | Treatment:Celecoxib_HFD | height |
Reversed phase NEGATIVE ION MODE | Celecoxib_HFD_4 | Treatment:Celecoxib_HFD | height |
Reversed phase NEGATIVE ION MODE | Celecoxib_HFD_5 | Treatment:Celecoxib_HFD | height |
Reversed phase NEGATIVE ION MODE | Celecoxib_HFD_6 | Treatment:Celecoxib_HFD | height |
Reversed phase NEGATIVE ION MODE | Celecoxib_HFD_7 | Treatment:Celecoxib_HFD | height |
Reversed phase NEGATIVE ION MODE | Celecoxib_HFD_8 | Treatment:Celecoxib_HFD | height |
Reversed phase NEGATIVE ION MODE | Celecoxib_HFD_9 | Treatment:Celecoxib_HFD | height |
Reversed phase NEGATIVE ION MODE | CFD_1 | Treatment:CFD | height |
Reversed phase NEGATIVE ION MODE | CFD_2 | Treatment:CFD | height |
Reversed phase NEGATIVE ION MODE | CFD_3 | Treatment:CFD | height |
Reversed phase NEGATIVE ION MODE | CFD_4 | Treatment:CFD | height |
Reversed phase NEGATIVE ION MODE | CFD_5 | Treatment:CFD | height |
Reversed phase NEGATIVE ION MODE | CFD_6 | Treatment:CFD | height |
Reversed phase NEGATIVE ION MODE | CFD_7 | Treatment:CFD | height |
Reversed phase NEGATIVE ION MODE | CFD_8 | Treatment:CFD | height |
Reversed phase NEGATIVE ION MODE | HFD_1 | Treatment:HFD | height |
Reversed phase NEGATIVE ION MODE | HFD_2 | Treatment:HFD | height |
Reversed phase NEGATIVE ION MODE | HFD_3 | Treatment:HFD | height |
Reversed phase NEGATIVE ION MODE | HFD_4 | Treatment:HFD | height |
Reversed phase NEGATIVE ION MODE | HFD_5 | Treatment:HFD | height |
Reversed phase NEGATIVE ION MODE | HFD_6 | Treatment:HFD | height |
Reversed phase NEGATIVE ION MODE | HFD_7 | Treatment:HFD | height |
Reversed phase NEGATIVE ION MODE | HFD_8 | Treatment:HFD | height |
Reversed phase NEGATIVE ION MODE | HFD_9 | Treatment:HFD | height |